𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C

✍ Scribed by Christophe Hézode; Elie Serge Zafrani; Françoise Roudot–Thoraval; Charlotte Costentin; Ali Hessami; Magali Bouvier–Alias; Fatiha Medkour; Jean–Michel Pawlostky; Sophie Lotersztajn; Ariane Mallat

Book ID
119760165
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
262 KB
Volume
134
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daily cannabis smoking as a risk factor
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C
✍ Christophe Hézode; Françoise Roudot-Thoraval; Son Nguyen; Pascale Grenard; Boris 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Cannabinoids present in Cannabis sativa (marijuana) exert biological effects via cannabinoid receptors CB1 and CB2. We recently demonstrated that CB1 and CB2 receptors regulate progression of experimental liver fibrosis. We therefore investigated the impact of cannabis smoking on fibrosis progressio

Hepatic steatosis is a risk factor for h
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
✍ Kazuyuki Ohata; Keisuke Hamasaki; Kan Toriyama; Kojiro Matsumoto; Akira Saeki; K 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 3 views

## Abstract ## BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of